Aspirin is a molecule. Chemists can draw it, make it, and make it again identically, essentially forever. That kind of product is what most people picture when they think of medicine.
Biologics are different. They come from living sources — cells, tissues, proteins produced by living systems. That single difference changes almost everything about how they are made, handled and regulated.
Why the difference matters practically
- They are complex. Biologic products are often large, intricate and difficult to characterise completely.
- They are sensitive. Heat, cold, time and handling can change them.
- They vary. Biological source material is never quite identical batch to batch, which is why lot information matters.
- They are regulated differently. Because they are complex and variable, oversight of biologics differs from oversight of conventional drugs.
So is a biologic automatically a treatment?
No. “Biologic” describes what something is made from, not what it has been shown to do. Some biologics are approved medicines with defined uses. Others are supplied for research purposes. Others are being investigated. The category name tells you about the origin, not the evidence.
That distinction is the single most common source of confusion in this field, and it is worth holding on to.
Why handling is part of the product
With a chemical tablet, storage is mostly a convenience question. With a biologic, storage can determine whether the product is still what it is supposed to be. A biologic that spent time outside its required temperature range may no longer be usable, even though nothing about it looks different.
This is why we treat handling and documentation as part of the product itself. See The Verified Standard™.